SCHEMBL22552406

SCHEMBL22552406

C=C(C)c1cn(-c2c(C)cccc2F)c(=O)c2ccccc12

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 11/20 0.54
KDM4E B2RXH2 3/20 0.41
LMNA P02545 3/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
PDE7A Q13946 2/20 0.39
ALDH1A1 P00352 1/20 0.39
HTR1A P08908 1/20 0.38
HTR2A P28223 1/20 0.38
HTR7 P34969 1/20 0.38
HTR6 P50406 1/20 0.38
PDE4A P27815 1/20 0.38
PDE4B Q07343 1/20 0.38
PDE4C Q08493 1/20 0.38
PDE4D Q08499 1/20 0.38
PDE7B Q9NP56 1/20 0.38
TP53 P04637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22552542 0.82 DHODH (0.55) DHODHKDM4ELMNAMEN1KMT2A
SCHEMBL22552530 0.81 KDM4E (0.45) DHODHKDM4ELMNAMEN1KMT2A
SCHEMBL30673355 0.81 KDM4E (0.45) DHODHKDM4ELMNAMEN1KMT2A
SCHEMBL22552187 0.80 DHODH (0.54) DHODHKDM4ELMNAMEN1KMT2A
SCHEMBL22552310 0.76 DHODH (0.52) DHODHPDE7APDE4APDE4BPDE4C
SCHEMBL22552517 0.76 DHODH (0.55) DHODHKDM4ELMNAMEN1KMT2A
SCHEMBL22552419 0.76 DHODH (0.54) DHODHKDM4ELMNAMEN1KMT2A
SCHEMBL22552423 0.76 DHODH (0.54) DHODHKDM4ELMNAMEN1KMT2A
SCHEMBL22552479 0.75 DHODH (0.54) DHODHKDM4ELMNAMEN1KMT2A
SCHEMBL22552654 0.71 DHODH (0.57) DHODHKDM4ELMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11753393-B2 Dihydroorotate dehydrogenase inhibitors JANSSEN BIOTECH, INC. 2023-09-12 US disclosed
US-11505536-B2 Dihydroorotate dehydrogenase inhibitors JANSSEN BIOTECH, INC. 2022-11-22 US disclosed
US-20220298137-A1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS JANSSEN BIOTECH INC (US) 2022-09-22 US disclosed
US-20200331881-A1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS JANSSEN BIOTECH, INC. 2020-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11753393-B2 Dihydroorotate dehydrogenase inhibitors DHODH, DLD, DPYD DHODH 1/4885KDM4E 1797/4885LMNA 3592/4885
US-11505536-B2 Dihydroorotate dehydrogenase inhibitors DHODH, DLD, DPYD DHODH 1/4885KDM4E 1797/4885LMNA 3592/4885
US-20220298137-A1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS DHODH, DLD, DPYD DHODH 1/4885KDM4E 1797/4885LMNA 3592/4885
US-20200331881-A1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS DHODH, DLD, DPYD DHODH 1/4885KDM4E 1797/4885LMNA 3592/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.